SPRO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Spero Therapeutics Inc (SPRO) is not a strong buy for a beginner investor with a long-term focus at this time. Despite a bullish technical setup, the lack of positive news, significant insider selling, poor financial performance, and no strong trading signals make it prudent to hold off on investing in this stock currently.
The stock shows a bullish technical setup with MACD positively expanding above 0, RSI indicating overbought conditions at 82.477, and moving averages aligned bullishly (SMA_5 > SMA_20 > SMA_200). The current pre-market price of $2.745 is above the pivot level of $2.501, with resistance at $2.727 and $2.866. However, the overbought RSI suggests a potential pullback in the short term.
The stock has a bullish technical setup, and options data shows a low put-call ratio, indicating a lack of bearish sentiment.
Insiders are selling heavily, with a 312.04% increase in selling activity over the last month. Financial performance in 2025/Q4 showed a significant decline in net income (-250.90% YoY), EPS (-221.05% YoY), and gross margin (-100.00% YoY). No recent news or congress trading data to support a positive outlook.
In 2025/Q4, revenue increased significantly by 174.51% YoY to $41.3M. However, net income dropped by -250.90% YoY to $31.5M, EPS fell by -221.05% YoY to $0.46, and gross margin dropped to 0%. This indicates poor profitability despite revenue growth.
No data on recent analyst ratings or price target changes is available.
